Publication Date:
2015-01-16
Description:
Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax) Cell Death and Disease 6, e1590 (January 2015). doi:10.1038/cddis.2014.561 Authors: J D Leverson, H Zhang, J Chen, S K Tahir, D C Phillips, J Xue, P Nimmer, S Jin, M Smith, Y Xiao, P Kovar, A Tanaka, M Bruncko, G S Sheppard, L Wang, S Gierke, L Kategaya, D J Anderson, C Wong, J Eastham-Anderson, M J C Ludlam, D Sampath, W J Fairbrother, I Wertz, S H Rosenberg, C Tse, S W Elmore & A J Souers
Electronic ISSN:
2041-4889
Topics:
Biology
,
Medicine
Permalink